Cabaletta Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	515	973	268	107	300	336
Market Cap Growth	-	262.43%	149.94%	-64.23%	-10.59%	-
Enterprise Value	313	736	167	-15	192	200
PE Ratio	-14.37	-14.37	-5.07	-2.32	-9.01	-15.08
PB Ratio	2.33	4.12	2.57	0.91	2.74	2.43
P/FCF Ratio	-17.93	-17.93	-5.50	-3.04	-10.95	-20.06
P/OCF Ratio	-18.16	-18.16	-5.79	-3.15	-11.21	-20.93
EV/EBITDA Ratio	-11.47	-11.47	-3.39	0.33	-5.81	-11.85
EV/EBIT Ratio	-10.88	-10.88	-3.15	0.32	-5.75	-11.78
EV/FCF Ratio	-13.58	-13.58	-3.42	0.42	-6.99	-11.92
Debt / Equity Ratio	0.02	0.02	0.05	-	-	-
Debt / EBITDA Ratio	-0.08	-0.08	-0.10	-	-	-
Debt / FCF Ratio	-0.09	-0.09	-0.11	-	-	-
Quick Ratio	15.08	15.08	11.23	14.58	20.98	43.28
Current Ratio	15.29	15.29	11.47	14.86	21.92	44.66
Return on Equity (ROE)	-40.80%	-40.80%	-54.00%	-42.20%	-27.60%	-34.90%
Return on Assets (ROA)	-37.90%	-37.90%	-49.90%	-40.00%	-26.70%	-25.40%
Return on Capital (ROIC)	-30.95%	-30.95%	-49.37%	-39.26%	-30.89%	-13.51%
Earnings Yield	-12.32%	-6.96%	-19.74%	-43.11%	-11.11%	-6.63%
FCF Yield	-9.87%	-5.58%	-18.20%	-32.85%	-9.13%	-4.99%
Buyback Yield / Dilution	-47.69%	-47.69%	-2.41%	-17.78%	-0.09%	-1253.67%
Total Shareholder Return	-47.69%	-47.69%	-2.41%	-17.78%	-0.09%	-1253.67%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).